Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Rathelot

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Plos One|September 4, 2025
Stability and physical compatibility of parenteral nalbuphine hydrochloride during continuous infusion in pediatricsRomain Paoli-Lombardo, Vincent Arcani, Delphine Dazan, et al.
Bioorganic & Medicinal Chemistry|April 8, 2015
Antileishmanial pharmacomodulation in 8-nitroquinolin-2(1H)-one seriesCharline Kieffer, Anita Cohen, Pierre Verhaeghe, et al.
Bioorganic & Medicinal Chemistry Letters|August 20, 2011
4-Thiophenoxy-2-trichloromethyquinazolines display in vitro selective antiplasmodial activity against the human malaria parasite Plasmodium falciparumPierre Verhaeghe, Aurélien Dumètre, Caroline Castera-Ducros, et al.
European Journal of Medicinal Chemistry|January 7, 2015
Looking for new antileishmanial derivatives in 8-nitroquinolin-2(1H)-one seriesCharline Kieffer, Anita Cohen, Pierre Verhaeghe, et al.
Therapie|June 14, 2014
[mediEVAL: a new evaluating tool for the medication-use system]Marion Bessone, Pascal Rathelot, Raffi Agopian, et al.
European Journal of Medicinal Chemistry|July 12, 2011
Targeting the human malaria parasite Plasmodium falciparum: in vitro identification of a new antiplasmodial hit in 4-phenoxy-2-trichloromethylquinazoline seriesCaroline Castera-Ducros, Nadine Azas, Pierre Verhaeghe, et al.
Annales Pharmaceutiques Francaises|February 27, 2025
[Training healthcare teams of a multi-site university hospital on high-alert medication issues: Using an escape room]Pierre Leroux, Caroline Castera-Ducros, Laurence Conreur, et al.
European Journal of Medicinal Chemistry|May 22, 2012
Discovery of a new antileishmanial hit in 8-nitroquinoline seriesLucie Paloque, Pierre Verhaeghe, Magali Casanova, et al.
European Journal of Medicinal Chemistry|June 20, 2014
Synthesis and in vitro evaluation of 4-trichloromethylpyrrolo[1,2-a]quinoxalines as new antiplasmodial agentsNicolas Primas, Peggy Suzanne, Pierre Verhaeghe, et al.
Bioorganic & Medicinal Chemistry|October 2, 2013
Targeting the human parasite Leishmania donovani: discovery of a new promising anti-infectious pharmacophore in 3-nitroimidazo[1,2-a]pyridine seriesCaroline Castera-Ducros, Lucie Paloque, Pierre Verhaeghe, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Plos One|September 4, 2025
Stability and physical compatibility of parenteral nalbuphine hydrochloride during continuous infusion in pediatricsRomain Paoli-Lombardo, Vincent Arcani, Delphine Dazan, et al.
Bioorganic & Medicinal Chemistry|April 8, 2015
Antileishmanial pharmacomodulation in 8-nitroquinolin-2(1H)-one seriesCharline Kieffer, Anita Cohen, Pierre Verhaeghe, et al.
Bioorganic & Medicinal Chemistry Letters|August 20, 2011
4-Thiophenoxy-2-trichloromethyquinazolines display in vitro selective antiplasmodial activity against the human malaria parasite Plasmodium falciparumPierre Verhaeghe, Aurélien Dumètre, Caroline Castera-Ducros, et al.
European Journal of Medicinal Chemistry|January 7, 2015
Looking for new antileishmanial derivatives in 8-nitroquinolin-2(1H)-one seriesCharline Kieffer, Anita Cohen, Pierre Verhaeghe, et al.
Therapie|June 14, 2014
[mediEVAL: a new evaluating tool for the medication-use system]Marion Bessone, Pascal Rathelot, Raffi Agopian, et al.
European Journal of Medicinal Chemistry|July 12, 2011
Targeting the human malaria parasite Plasmodium falciparum: in vitro identification of a new antiplasmodial hit in 4-phenoxy-2-trichloromethylquinazoline seriesCaroline Castera-Ducros, Nadine Azas, Pierre Verhaeghe, et al.
Annales Pharmaceutiques Francaises|February 27, 2025
[Training healthcare teams of a multi-site university hospital on high-alert medication issues: Using an escape room]Pierre Leroux, Caroline Castera-Ducros, Laurence Conreur, et al.
European Journal of Medicinal Chemistry|May 22, 2012
Discovery of a new antileishmanial hit in 8-nitroquinoline seriesLucie Paloque, Pierre Verhaeghe, Magali Casanova, et al.
European Journal of Medicinal Chemistry|June 20, 2014
Synthesis and in vitro evaluation of 4-trichloromethylpyrrolo[1,2-a]quinoxalines as new antiplasmodial agentsNicolas Primas, Peggy Suzanne, Pierre Verhaeghe, et al.
Bioorganic & Medicinal Chemistry|October 2, 2013
Targeting the human parasite Leishmania donovani: discovery of a new promising anti-infectious pharmacophore in 3-nitroimidazo[1,2-a]pyridine seriesCaroline Castera-Ducros, Lucie Paloque, Pierre Verhaeghe, et al.
Pageof 5